Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 258-266

  Abdelsamie, Souzan A ^b   Li, Yanchun ^b   Huang, Yan ^a,b   Lee, Mi Hye ^b   Klein, Richard L ^a,b   Virella, Gabriel ^b   Lopes Virella, Maria F ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Collagen; Immune complexes; Low density lipoprotein; Mesangial cells; Nephropathy

Indexed keywords

CD16 ANTIGEN; COLLAGEN TYPE 4; FC RECEPTOR; FC RECEPTOR 1; FC RECEPTOR 2; GAMMA INTERFERON RECEPTOR 1; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESANGIUM CELL; OXIDATION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGEN-ANTIBODY COMPLEX; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; FLOW CYTOMETRY; GLOMERULAR MESANGIUM; HUMANS; IMMUNOBLOTTING; LIPOPROTEINS, LDL; MESANGIAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 79955962025     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.01.016     Document Type: Article

References (42)

1. Dronavalli S., Duka I., Bakris G.L. The pathogenesis of diabetic nephropathy. Nature clinical practice. Endocrinol. Metab. 2008, 4:444-452.
2. Akmal M. Hemodialysis in diabetic patients. Am. J. Kidney Dis. 2001, 38:S195-S199.
3. Doi T., Mima A., Matsubara T., Tominaga T., Arai H., Abe H. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy. Diab. Res. Clin. Pract. 2008, 82(Suppl 1):S21-S24.
4. Dalla Vestra M., Saller A., Mauer M., Fioretto P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J. Nephrol. 2001, 14(Suppl 4):S51-S57.
5. Mason R.M., Wahab N.A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 2003, 14:1358-1373.
6. Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J. Am. Soc. Nephrol. 1994, 5:1165-1172.
7. Klahr S., Schreiner G., Ichikawa I. The progression of renal disease. N. Engl. J. Med. 1988, 318:1657-1666.
8. Marx M., Sterzel R.B., Sorokin L. Renal matrix and adhesion in injury and inflammation. Curr. Opin. Nephrol. Hypertens. 1993, 2:527-535.
9. Steffes M.W., Osterby R., Chavers B., Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989, 38:1077-1081.
10. Rosenblum N.D. The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int. Suppl. 1994, 45:S73-S77.
11. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987, 1:272-281.
12. Schiffer M.S., Michael A.F., Kim Y., Fish A.J. Distribution of glomerular basement membrane antigens in diseased human kidneys. Lab. Invest. 1981, 44:234-240.
13. Floege J., Johnson R.J., Gordon K., Iida H., Pritzl P., Yoshimura A., Campbell C., Alpers C.E., Couser W.G. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 1991, 40:477-488.
14. Mene P., Simonson M.S., Dunn M.J. Physiology of the mesangial cell. Physiol. Rev. 1989, 69:1347-1424.
15. Kashgarian M., Sterzel R.B. The pathobiology of the mesangium. Kidney Int. 1992, 41:524-529.
16. Abrass C.K., Peterson C.V., Raugi G.J. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988, 37:1695-1702.
17. Courtoy P.J., Timpl R., Farquhar M.G. Comparative distribution of laminin, type IV collagen, and fibronectin in the rat glomerulus. J. Histochem. Cytochem. 1982, 30:874-886.
18. Gomez-Guerrero C., Lopez-Armada M.J., Gonzalez E., Egido J. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J. Immunol. 1994, 153:5247-5255.
19. Lee H.S., Kim Y.S. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int. 1998, 54:848-856.
20. Lee H.S. Oxidized LDL, glomerular mesangial cells and collagen. Diab. Res. Clin. Pract. 1999, 45:117-122.
21. Lopes-Virella M.F., Virella G. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Front. Biosci. 2003, 8:s750-s768.
22. Mironova M., Virella G., Lopes-Virella M.F. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler. Thromb. Vasc. Biol. 1996, 16:222-229.
23. Virella G., Koskinen S., Krings G., Onorato J.M., Thorpe S.R., Lopes-Virella M. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Clin. Immunol. 2000, 95:135-144.
24. Lopes-Virella M.F., McHenry M.B., Lipsitz S., Yim E., Wilson P.F., Lackland D.T., Lyons T., Jenkins A.J., Virella G. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 2007, 190:359-369.
25. Couser W.G. Mechanisms of glomerular injury in immune-complex disease. Kidney Int. 1985, 28:569-583.
26. Sedor J.R., Carey S.W., Emancipator S.N. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release. Evidence for an Fc receptor. J. Immunol. 1987, 138:3751-3757.
27. Neuwirth R., Singhal P., Diamond B., Hays R.M., Lobmeyer L., Clay K., Schlondorff D. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells. J. Clin. Investig. 1988, 82:936-944.
28. Knauss T.C., Mene P., Ricanati S.A., Kester M., Dubyak G.R., Emancipator S.N., Sedor J.R. Immune complex activation of rat glomerular mesangial cells: dependence on the Fc region of antibody. Am. J. Physiol. 1989, 257:F478-F485.
29. Lopez-Armada M.J., Gomez-Guerrero C., Egido J. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J. Immunol. 1996, 157:2136-2142.
30. Saad A.F., Virella G., Chassereau C., Boackle R.J., Lopes-Virella M.F. OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J. Lipid Res. 2006, 47:1975-1983.
31. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Investig. 1989, 84:1086-1095.
32. Huang Y., Fleming A.J., Wu S., Virella G., Lopes-Virella M.F. Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2533-2538.
33. Nicholson A.C., Frieda S., Pearce A., Silverstein R.L. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 1995, 15:269-275.
34. Wilson K.C., Finbloom D.S. Interferon gamma rapidly induces in human monocytes a DNA-binding factor that recognizes the gamma response region within the promoter of the gene for the high-affinity Fc gamma receptor. Proc. Natl Acad. Sci. USA 1992, 89:11964-11968.
35. Atchley D.H., Lopes-Virella M.F., Zheng D., Kenny D., Virella G. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 2002, 45:1562-1571.
36. Virella G., Carter R.E., Saad A., Crosswell E.G., Game B.A., Lopes-Virella M.F. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. Clin. Immunol. 2008, 127:394-400.
37. Navarro-Gonzalez J.F., Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19:433-442.
38. Torffvit O., Agardh C.D., Alm P., Wieslander J. Urine and serum levels of the carboxyterminal domain (NCl) of collagen IV in membranous glomerulonephritis and diabetic nephropathy. Nephron 1991, 59:15-20.
39. Daeron M. Fc receptor biology. Annu. Rev. Immunol. 1997, 15:203-234.
40. Medeiros L.A., Khan T., El Khoury J.B., Pham C.L., Hatters D.M., Howlett G.J., Lopez R., O'Brien K.D., Moore K.J. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 2004, 279:10643-10648.
41. Fronhofer V., Lennartz M.R., Loegering D.J. Role of PKC isoforms in the Fc(gamma)R-mediated inhibition of LPS-stimulated IL-12 secretion by macrophages. J. Leukoc. Biol. 2006, 79:408-415.
42. Larsen E.C., Ueyama T., Brannock P.M., Shirai Y., Saito N., Larsson C., Loegering D., Weber P.B., Lennartz M.R. A role for PKC-epsilon in Fc gammaR-mediated phagocytosis by RAW 264.7 cells. J. Cell Biol. 2002, 159:939-944.